ctxr: the balance sheet

MyFinsight

For the quarter ending 2025-06-30, CTXR has $127,676,859 in assets. $60,115,929 in debts. $6,089,126 in cash and cash equivalents.

Unit: Dollar

Balance Sheets	2025-06-30
Goodwill	9,346,796
Deposits	38,062
In-process research and development	92,800,000
Total other assets	102,184,858
Prepaid expenses	1,313,176
Inventory	17,208,967
Cash and cash equivalents	6,089,126
Total current assets	24,611,269
Operating lease right-of-use asset, net	880,732
Total assets	127,676,859

Accumulated deficit	-230,844,841
Common stock - 0.001 par value 250,000,000 and 16,000,000 shares authorized 14,475,029 and 7,247,243 shares issued and outstanding at june 30, 2025 and september 30, 2024, respectively	14,475
Additional paid-in capital	295,888,916
Total citius pharmaceuticals, inc. stockholders equity	65,058,550
Non-controlling interest	2,502,380
Total equity	67,560,930
Operating lease liability	114,694
Note payable	1,000,000
Accrued compensation	3,710,041
Accrued expenses	8,523,675
Accounts payable	10,094,042
License payable	28,400,000
Total current liabilities	51,842,452
Operating lease liability - noncurrent	766,957
Deferred tax liability	7,506,520
Total liabilities	60,115,929
Total liabilities and equity	127,676,859